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Abstract
Multiparametric echocardiographic imaging of the failing heart is now increasingly used and useful
in decision making in heart failure. The reasons for this, relies on the need of different strategies of
handling these patients, as differentiation of systolic or diastolic dysfunction, as well as on the
gamma of approaches available, such as percutaneous and surgical revascularization, devices
implantations, and valvular regurgitations and stenosis corrections. Congestive heart failure in
patients with normal left ventricular diameters or preserved left ventricular ejection fraction had
been pointed out recently as present in a proportion so high as 40 to 50 percent of cases of heart
failure, mainly due to the epidemics in well developed countries, as is the problem of not well
controlled metabolic states (such as obesity and diabetes), but also due to the real word in
developing countries, as is the case of hypertension epidemics and its lack of adequate control. As
a matter of public utility, the guidelines in the diagnosis and treatment of such patients will have to
be cheap, available, easily reproducible, and ideally will furnish answers for the clinician questions
not in a binary "black or white" manner, but with graduations, so if possible it has to be quantitative.
The present paper aim to focus on the current clinical applications of tissue Doppler and of left
atrial function and remodeling, and its pathophysiologic relationship with the left ventricle, as will
be cleared in the documented review of echocardiography that follows, considering that the need
of universal data on the syndrome of the failing heart does not mean, unfortunately, that all patients
and clinicians in developing countries have at their own health facilities the same imaging tools, since
they are, as a general rule, expensive.
Heart failure and its epidemiological importance
Heart failure is considered a world endemic problem and
data ratified by The European Society of Cardiology
(ESC), according to recent publications, estimates a prev-
alence of symptomatic manifestations in the general Euro-
pean population ranging from 0.4 to 2% [1]. In other
countries, for over three decades, acute myocardial infarc-
tion (AMI) is the most frequent cause of deaths among the
adult population – as, for instances, seen in southern Bra-
zilian cities-, and mortality exhibits increase for both sexes
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as the age increases [2]. Cardiac failure (CF) in fact is a
complex syndrome, embracing systemic complications
determined by all forms of heart disease, and it is the com-
mon end for the most prevalent illnesses, like the athero-
sclerotic coronary disease and systemic arterial
hypertension (SAH). The population percentage growth
of elderly people in Brazil is a fact, at it is estimated to be
around 30 million over 60 years of age in 2025, or 15% of
the expected Brazilian population for the period [3], and
this will much contribute for the increase of incidence and
prevalence in the rates of heart failure. In this context, the
epidemiological importance of the syndrome justifies the
significant growing interest in the research area through
the organization of CF specific investigation centers in
University hospitals, and public policies of investment
aiming at primary or secondary prevention of the risky
population.
Heart structure redefinition and function 
importance in the cardiac failure study
Under the physiopathologic point of view, CF is character-
ized as myocardial function failure. Without neglecting
the autonomous nervous system hormonal mechanisms
or the other adapting or deleterious bimolecular implica-
tions, the most relevant aspect is that, in this case, the car-
diac structure does not provide contraction and ejection
with sufficient systolic volume, and does not promote the
adequate diastolic arrangements or both situations are
not processed appropriately. And this heart dysfunction is
closely associated with the heart geometric structural alter-
ations. According to this statement, the aggregation of CF
diagnostic stratification is mentioned, not only based on
clinical symptom classes but also associated with struc-
tural dysfunction stages (A, B and D) proposed by the
Sociedade Brasileira de Cardiologia [3] and the American Col-
lege of Cardiology/American Heart Association [4] the guide-
lines for the CF diagnosis and clinical care. This
proposition suggests all the manners of incorporating
information on etiology data, physiopathology, geomet-
ric structure and heart function which range from an
absent situation of structural heart alteration (phase A) to
a terminal stage of myocardial dysfunction (phase D). At
the same time, another recent highly interesting focus on
the CF study involves the discussion of the actual impor-
tance in the search for information related to the left ven-
tricular systolic and diastolic functions (LV) [5]. A direct
consequence of this discussion is the conceptual division
in CF with preserved contractile function and contractile
dysfunction [6,7]. Recent population-based studies have
shown an about equal prevalence of both with a higher
mortality rate in the systolic dysfunction group, however,
with similar indices in terms of morbidity [8]. Therefore,
a new conception if CF emerged with the need for a con-
ceptual definition based on the analysis of the LV systolic
and diastolic function generating a dynamic and constant
discussion on the method of cardiac functional assess-
ment, the use of LV geometry additional data, the left
atrium and direct chamber functions as well as the func-
tional capacity indices. The complexity of the CF diagnos-
tic clinical approach has increased in the last decade; on
the other hand, with the advent of many heart evaluation
indices, there is an increasing need to define which
actions are really effective, the signified levels, its effect
size and the cost which they represent.
Diastolic function evaluation in cardiac failure 
patients
The LV diastolic function can be measured by estimate or
index direct measurement through various cardiovascular
imaging methods: radioisotopic ventriculography, heart
catheterization, and magnetic resonance imaging, how-
ever, the echocardiographic-Doppler study is the most
applied tool, due to its high feasibility of transmitral Dop-
pler indices, almost universal availability and low cost [9].
Echocardiography by transmitral pulsed 
Doppler and pulmonary veins: a description of 
classical qualitative patterns and method 
limitations
Since 1980, the pulsed Doppler technique for the left ven-
tricular analysis allows the diastole study in a noninvasive
form, initially in animals then in human beings [10]. The
information obtained with the technique permits stand-
ardization within acceptable variations of what the nor-
mal and the alternate diastole are in terms of
echocardiography.
Various studies have used the transmitral Doppler (TD)
recognizing normal and alternate diastole patterns.
According to the technical point of view, the TD analyzes
the blood flow by measuring the high frequency signals
and the low amplitude of the blood cells [11]. The
method proposes the following indices for the diastolic
analysis: E-wave (early ventricular filling); A-wave (late
ventricular filling); E/A ratio; isovolumic relaxation time
(IVRT); E-wave peak velocity (E); E-wave deceleration
time (EDT), A-wave duration (A-dur). The flow analysis
by pulsed Doppler of the pulmonary veins allows the
acquisition of additional indices: flow systolic peak (S) –
divided in S1 an S2-flow diastolic peak (D), atrial reverse
flow peak (AR) and duration rate of this reverse flow (AR-
dur). Important information for the diastolic pattern char-
acterization is obtained through a detailed analysis of the
available parameter set, making use of the transmitral
Doppler method and the pulmonary veins, as follows: (a)
normal function: generally observed in youngsters; the
early filling is dominant with E/A ratio > 1. There is a light
predominance of peak D and AR and AR-dur minimal
amplitude; deficient relaxation or relaxation deficit: there
is a minor peak of early filling velocity; therefore, the E/ACardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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ratio is > 1. The IVTR and the EDT are higher. In pulmo-
nary veins, the D velocity according to the E-wave is
diminished and compensated by the systolic S flow. The
AR and the AR-dur usually remain unchanged but can
increase according to the elevation of the LV final diastolic
pressure. The pattern is related to ischemia, hypertrophy
or even to infiltrative cardiomyopathies in initial stage;
(b) Pseudonormal pattern: it presents an E/A > 1 ratio as the
normal pattern; however, it reflects a velocity increase of
the E-wave flow secondary to the pressure elevation in the
left atrium, a relaxation deficit and an initial decrease of
the LV compliance. The IVTR is diminished due to the
higher initial transmitral gradient. The pulmonary venous
flow presents abnormal D velocity predominance as this
one relates with the increase of the early mitral flow (E-
wave). This situation represents an ischemia dysfunction
progression, hypertensive or LV overload eventually
becoming difficult to differentiate in relation to the real
normal pattern; (c) restrictive pattern: the velocity of the
early diastolic filling is increased which results in E/A ratio
> 2 and in an IVTR and EDT decrease. In this case, the
rapid blood flow to the less complacent ventricle results in
a rapid elevation of the LV filling pressure, supplanting
the atrial pressure which could also cause ventricle-atrial
regurgitation in the diastolic phase. As it was observed in
the previous pattern, there is here a pulmonary venous
flow diastolic increase which corresponds to the transmi-
tral E-wave elevation. The AR and the AR-dur are increased
and they keep a positive correlation with the LV final
diastolic pressure. The restrictive pattern is related to
advanced stages of heart failure and with the worst clinical
prognosis (Figure 1).
The TMD index contribution to the CF diagnostic and
prognostic measurement is undeniable [12-15], even
though the method is questionable under the technical
point of view. The difficulties and limitations are based on
the variability in different clinical and haemodynamic
conditions. The effects of the left atrial pressure variation
on the LV preload different degrees eventually produce a
pseudonormalization or even a restrictive pattern type; the
heart rate elevation leads to the velocity alterations and
often to the spectral Doppler wave fusion with a conse-
quent loss of the qualification analysis of the ratio
between the waves. Meanwhile, the LV preload variable
status can also set alterations inversely proportional in the
TMD indices. It is reasonable, however, that this method
LV diastolic indices measured by transmitral Doppler Figure 1
LV diastolic indices measured by transmitral Doppler. E: LV early filling flow velocity; A: late filling flow velocity; EDT: 
E-wave deceleration time; IVRT: LV isovolumic myocardial relaxation time.
IVRT 
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is complemented with others for a comprehensive ven-
tricular filling function analysis [16].
Pulsed tissue Doppler contribution for the 
diastolic measurement
The tissue pulsed Doppler (TPD) consists of a modality
linked with the echocardiography by Doppler which
allows the estimate of the myocardial displacement veloc-
ity during the cardiac cycle analysing signals of low fre-
quency and high amplitude produced by the myocardial
tissue [11].
The myocardial velocity phenomenon can be analyzed by
three models: bidimensional coded by color, unidimen-
sional coded by color, and the more commonly used, the
pulsed spectral mode, with which the systolic myocardial
displacement S', and the E' and A' waves can be respec-
tively registered (Figures 2 and 3).
The tissue Doppler E' velocity index is primarily influ-
enced by left atrial pressure, left ventricle relaxation and
left ventricle systolic pressure in order of decreasing signif-
icance [16], and for its procedure, this and the other indi-
ces are taken with the volume-sample placement in the
myocardial region next to the mitral valve ring in the LV
septal and lateral wall or in any other myocardial segment
which will be measured [17]. This possibility in various
myocardial segments confers the "segmental diastolic"
information acquisition property, which can also be use-
ful in myocardial ischemia investigation and in the ven-
tricular dissynchronism analysis [18].
Which evidences do validate the tissue Doppler 
index addition?
The TMD index susceptibility, in relation to the LV
preload variations, represents this method main disad-
vantage for the diastolic analysis in a global manner. The
TPD indices contribute to a less susceptible measurement
to the preload variation. In a recent study performed by
our research group, we have observed that in the hyper-
tensive diastolic measurement, there was not significant
variation of E' index with the bedside noninvasive maneu-
vers that induces the preload elevation (E' = 8.2 ± 2.3 cm/
s × E' = 8.3 ± 2.2 cm/s, P = NS), while the TMD index E has
varied significantly (E = 68.9 ± 11.9 cm/s × E = 75.8 ± 15.7
cm/s), (Figure 4). This property could be very helpful in
the differentiation between the normal and pseudonormal-
ized patterns [19,20].
LV diastolic pattern by tissue Doppler Figure 2
LV diastolic pattern by tissue Doppler. S': LV systolic myocardial displacement velocity; E': LV early diastolic displacement 
velocity; A: LV late diastolic displacement velocity.
E ’
A ’
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Mitral Doppler and tissue pulsed Doppler indices 
in basal condition and elevation of preload
In the invasive study model, Sohn et al [21], already
showed the advantages of this method in relation to the
transmitral flow summarized in the preload reduced
influence in the E' variable obtained by TPD. While ana-
lysing 20 patients with diastolic dysfunction by altered
relaxation – detected by transmitral Doppler – an abnor-
mal relaxation diastolic pattern change to pseudonormal-
ized was observed after the infusion of 500 to 700 ml of
saline physiological solution (0.9% NaCl concentration),
but the TPD diastolic pattern analysis did not show any
significant alteration (E' = 5.3 ± 1.2 cm/s × E' = 5.7 ± 1.4
cm/s, P = NS).
This TPD index behavior was partially questioned in a
recent publication by Hsiao et al. [22] in which the
authors have studied 81 patients in hemodialysis without
segmental contractile alterations, stratified according to
the weight loss post-dialysis and observed preload inde-
LV diastolic patterns measured by transmitral Doppler of the pulmonary flow and tissue Doppler Figure 3
LV diastolic patterns measured by transmitral Doppler of the pulmonary flow and tissue Doppler. E/A ratio 
between the LV early filling flow E velocity and late flow A measured by transmitral Doppler EDT: E-wave deceleration time; S: 
pulmonary flow systolic velocity peak; D: pulmonary flow diastolic velocity peak; RA: retrograde atrial velocity peak; RA-dur: 
retrograde atrial flow duration; ms: milliseconds; E/E: ratio between the early filling flow E velocity measured by transmitral 
Doppler and the LV early diastolic myocardial displacement E' velocity measured by tissue Doppler.Cardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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pendence when the dialytic loss was less than 2 kg. When
the loss was higher, the TPD varied significantly. Even so,
it is consensual the fact that the technique is less pre-load
dependent than the traditional DTM indices and that it
adds significant information to the diastolic evaluation.
However, in a population similar to the one referred
above, and original study has shown in counterpoint to
the latter, that there was no significant variation in the
TPD, E', A', and E'/A' indices before preload variation by
lower member sustained elevation imposed on patients of
all ages, one hour after the hemodialysis, while the MTD,
E, A and E/A indices varied significantly [23]. It is
extremely important to emphasize that the E' index
reflects the early ventricular relaxation and it has also been
validated against the Tau index (time constant isovolumic
relaxation), considered the gold-standard for LV myocar-
dial relaxation, according to Sohn et al. [21]. In this study,
the authors have obtained a correlation between E' and
Tau (r = -0.56, P < 0.01) in 38 volunteers with relaxation
abnormalities. Recently, an important study has been
published by Nagueh et al. [24] in which there were an
attempt to relate MTD and TPD data with pulmonary cap-
illary pressure measures through pulmonary artery cathe-
terization of 60 volunteers.
When both methods (MTD and TPD) were used in E/E'
ration, a strong and statistically significant correlation was
obtained with the capillary pressure measured by catheter
(r = 0.87, P < 0.001). Besides, the study allowed the veri-
fication of patients with E/E' ration > 10 predicting a pul-
monary capillary pressure > 15 mmHg with 97%
sensibility and 78% specificity, and this study has placed
the E/E' ratio in a quite promising position, as a diastolic
index, stimulating many other subsequent studies.
Ommen et al. [25], while analysing 150 consecutive
patients set out for cardiac catheterization and submitting
them to an echocardiograph evaluation MTD and DPT
concomitantly to the intraventricular pressure measure-
ment, have verified a significant correlation of the E/E'
ratio with the measured LV diastolic average pressure (r =
0.63), and E/E' > 15 which was associated with a ventricu-
lar pressure above 15 mmHg with 86% specificity (with a
64% positive predictable value). In 2001, Nagueh et al.
[26] identified a strong correlation with the Tau index (r =
0.83, P < 0.001) and the pressure negative variation over
the LV time variation (-dP/dt) (r = 0.8, P < 0.001), another
parameter used in the LV relaxation assessment, aiming at
better studying myocardial diastolic velocity determinants
by Doppler tissue in animal sample with left atrium (LA)
and LV pressure catheterization and measurement. For the
first time in this study, the LA hemodynamic data are
investigated invasively in relation to the TPD indices pre-
senting a significant association between them: the A' late
diastolic velocity was significantly correlated with the dP/
dt (r = 0.67, P = 0 < 0.01), and with the LA relaxation
index (r = 0.67, P < 0.01). Additionally, there was an
inverse and significant correlation with the LA final
diastolic pressure, which also reflects indirectly the LA
hemodynamic behavior (r = 0.53, P < 0.001). Another
concern, regarding the diastolic evaluation in patients
with probable CF, is the lack of an isolated TMD index
reproducibility when evaluated in an altered rhythmic sit-
uation, as is the case of atrial fibrillation or sinus tachycar-
dia. Some studies, including the TPD indices, have
approached this problem recently. In 1999, Sohn et al.
[27] studied LV invasive hemodynamic measurement
data concomitantly with echocardiography with TMD and
TPD in 27 patients with atrial fibrillation of non-rheu-
matic etiology. The E/E' ratio had a positive correlation
with the left ventricular filling pressure (r = 0.79, P <
TMD and TPD indices in basal condition and preload increase Figure 4
TMD and TPD indices in basal condition and preload increase.
E velocity (cm/s) E’ velocity (cm/s)
REST ↑PRELOAD REST ↑PRELOADCardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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0.001). When this index presented values ≥ 11 it allowed
the prediction of LV high filling pressure (≥ 15 mmHg),
with a 75% sensibility and 93% specificity. Another study
by Nagueh et al. [28], while evaluating 100 patients with
a heart rate ≥ 100 beats/minute, described a positive and
significant correlation between the E/E' ratio and the pul-
monary capillary pressure value (r = 0.86, P < 0.01). An
equation, was also proposed by this author and has
shown a strong correlation with the pulmonary capillary
pressure measured by catheterization (r = 0.91, P < 0.05).
The evidences of such transversal study commented here
for small populations, and some of them not using the
real gold-standard for comparison, can still be questioned
regarding its validity. However, when information arises
from some recent data from a group of people added,
involving Doppler indices in patients with CF, there is an
awareness of the prognostic prediction power in mortality
regarding hard events in patient groups with chronic atrial
fibrillation [29], survival in the post myocardial infarct
period [30], or with systolic heart failure, as in the ADEPT
study [31]. Finally, it is important to emphasize that the
Doppler tissue analysis does not aggregate additional cost
to the exam and the necessary time for the acquisition of
such indices is not relevant.
The LV remodeling evaluation: is it a landmark 
in the etiologic, diagnostic and prognostic 
investigation in patients with CF?
The LV remodeling is generated by mechanical, neurohu-
moral, and possibly genetic factors which alter the ven-
tricular dimension, morphology and function. It can
occur in response to the aggressions in many clinical con-
ditions including severe or chronic ischaemia, cardiomy-
opathies, hypertension and valvular and infectious
disease. In the structural alteration diagram, hypertrophy,
myocyte loss and the interstitial fibrosis increase, com-
pose the tissue physiopathologic aspect associated with a
progressive dysfunction. In its conception, the CF cause
and consequence precepts are superimposed [32], as the
mechanisms responsible for its genesis can generate a
retro feeding or vicious cycle, worsening the geometric
pattern progressively. The elucidation of the mechanisms
responsible for the prevention and/or remodeling process
reversibility is one of the most important CF investigation
areas. The interventions which have already showed posi-
tive impact on the survival rate have a favorable action on
the myocardial remodeling process [33]. It can be
observed with angiotensin conversion enzyme inhibited
medication [34], beta-blockers [35], and even in more
complex therapies like accessory circulatory support [36]
and stem cell therapy, as proposed in the TOPCARE-AMI
study [37]. These evidences confer to the remodeling indi-
ces the substitutive parameter epidemiologic distinction
associated with strong clinical outcomes like mortality
becoming an essential element to be analyzed in the clin-
ical practice involving CF patients. A pertinent example is
the possibility of a LV remodeling index, as the LV mass
ratio index/corporal surface (IMVE) showing a ventricular
hypertrophic remodeling pattern, to be able to signal a
hypertensive etiology as the hypertrophy and the arterial
hypertension are commonly associated, as suggested in
the ICARE study [38]. The same geometry index can
simultaneously quantify the severity level of a hyperten-
sive cardiac disease and determine the prognosis in terms
of cardiovascular mortality, general mortality and cerebral
vascular accident. According to a study by Devereux et al.
[39], in a group of 941 patients with left ventricular hyper-
trophy whose myocardial mass was measured by echocar-
diography followed up by a 4.8 year average period,
regarding the major cardiovascular events at the end, there
was an association between the lowest ventricular mass
index (patients with anti-hypertensive treatment) and
lower cardiovascular mortality rate (HR = 0.62; CI 95%
0.47–0.82; P = 0.001), lower cerebrovascular rate (HR =
0.76; CI 95% 0.60 – 0.96; P = 0.02) and lower mortality
for all the causes (HR = 0.72; CI 95% 0.59 – 0.88; P =
0.002) So, it can be concluded that the information con-
ferred by LV remodeling qualitative and quantitative anal-
ysis can be somehow important for the CF clinical
approach and investigation.
The LV diastolic function and remodeling
The study of the changes in the association in ventricular
geometry with the worsening of specific diastolic stages –
LV relaxation, and compliance or stiffness – represents an
interesting focus. While still insisting on the association
between SAH and ventricular dysfunction remodeling in a
patient with CF, it is important to remember that, in this
case, the hypertrophy works as an adaptive mechanism for
the LV pressure overload involving the muscular and non
muscular heart compartment. Various studies suggest the
role of the contractile protein increase in the myocyte with
a subsequent increase of this cell, and followed by the col-
lagen matrix remodeling and the sustained growth in the
deposition of this element in the interstitial space. The
natural history of this process is the worsening of the myo-
cardium active relaxation and the increase of the chamber
stiffness causing LV filling dysfunction [40]. Studies on LV
hypertrophy using biopsy and hemodynamic data suggest
that the existent myocardial fibrosis contribute to the
diastolic pressure increase and alters the chamber disten-
sibility when the amount of fibrosis increases more than
15 to 20% [41]. Characterization of pathological hyper-
trophy is important as a diastolic dysfunction genesis. In
a physiological hypertrophy situation, in response to
physical exercises, there is the proportionality of the vas-
cular, interstitial and muscular components. This tissue
homogeneity in hypertrophy observed in athletes is not
associated with the diastolic pattern dysfunction, but withCardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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an adaptation of the relaxation myocardial velocity
increase and normal profile maintenance of the LV late
and early filling flow ratio [42]. In the pathological hyper-
trophy there is a growth of the nonmuscular component
of the myocardium with intercompartmental proportion-
ality loss. While investigating this sub-item, Villari et al.
[43] have studied patients with hypertrophy due to aortic
stenosis separating them in three different groups accord-
ing to the myocardial biopsy results: the first group with
collagen total volume fraction increase but without colla-
gen fibers disorganization pattern; the second one, with
fiber disorganization with no collagen volume fraction
increase, and the third one with fiber disorganization and
collagen increase. The author has observed an exponential
ratio between the collagen volume and the constant ven-
tricular stiffness. This correlation was not observed in
group 2, which presented a collagen normal volume and
a highly constant LV stiffness. This discrepancy can be
explained by the differences in the collagen fibrillar distri-
bution and architecture and indicates that not only the
collagen amount but also its distribution and configura-
tion determine the LV myocardial elastic property role.
The hypertrophy relation with LV relaxation alteration has
also been investigated and deserves some special consid-
eration. In relation to patients with systemic arterial
hypertension, Oki et al. [44] have studied the diastolic
dysfunction by echocardiography with Doppler using two
groups of individuals: fifty hypertensive patients and
thirty six normal volunteers, and submitted them to TMD
and TPD analysis. The results showed a myocardial relax-
ation velocity significantly lower in the hypertensive
group. Besides, there was a significant correlation (r =
0.80, P < 0.001) between the myocardium early displace-
ment velocity and the Tau index, rectifying previous find-
ings [21]. The classification of the hypertrophic LV
geometric configuration types in remodeling stages have
also demonstrated clinical relevance and preliminary
echocardiographic studies have already shown some
worsening correlation degree of the ventricular diastolic
function with its geometric alteration degree. In the LIFE
study analysis, Wachtell et al. [45] have found an isomet-
ric relaxation time, as well as a LV relaxation measure-
ment, significantly higher in hypertensive patients with a
higher geometric mass pattern. In the following year, a
Chinese group published in the Hypertension Research [46]
a study which approaches this question more deeply. Ana-
lysing a group with 117 hypertensive patients and 45 nor-
mal volunteers with echocardiography to obtain mass
index data and parietal thickness ratio, which were used to
characterize the normal geometry (N), concentric remod-
eling (CR), concentric hypertrophy (CH) and eccentric
hypertrophy (EH) groups according to Ganau et al. [47],
and measuring its relation with the Doppler diastolic pat-
terns (MTD only), this author has observed a progressive
worsening of the diastolic indices as the hypertrophy pat-
terns became more severe. There was a significant differ-
ence of these indices especially in the groups with CH and
EH in relation to the ones with normal geometry. Some
recent findings were demonstrated recently in a substudy
of a larger project named HyperGEN Study [48] with 1,384
hypertensive individuals, in which LV filling pattern anal-
ysis by Doppler and by TMD (E/A, IVRT and EDT) was
compared with four different geometry patterns as said
previously. The abnormal relaxation TMD pattern of the
European Society of Cardiology [49] was observed in 20% of
the patients. The E/A, and IVRT did not show an abnormal
relaxation pattern when compared to the presence of LV
hypertrophy, but they indicated such behavior when the
hypertrophy was concentric (P < 0.001). The application
of logistic regression test has revealed that the chances for
an abnormal relaxation pattern to occur were two to three
times higher in CH in relation to the LV normal geometric
pattern. These last two studies have rectified the previous
propositions and seem to have validity for an universe of
hypertensive patients with remodeling and with no con-
tractile and filling dysfunction severity, however, the
authors have worked only with TMD diastolic parameters,
a fact which was left out by the authors of the previous
study and can limit the evidence of the findings as it was
mentioned earlier, since the behavior of these indices is
affected by the LV preload which determines a non linear
distribution character, but ellipsoid in relation to the ven-
tricular filling pressure value. Clarifying, an E/A ratio
higher in relation to another one does not necessarily
mean that in the second patient a better diastolic status
would be expected. By analysing all the evidence context
of the LV remodeling relation with its diastolic function,
however, one cannot conceive a disconnection of one
with the other but a new perception when aggregating
geometric structure and function seems more rational and
adequate. Would this way of thinking be complete with-
out adding information regarding the anatomy data and
atrial function?
The left atrium: pump, reservoir, conduct or a 
dam?
The discussion on the left atrial physiology must be pre-
ceded by a brief review of the liquid dynamic concepts
and based on this, a combination with the basic notions
of its wall contractility, compliance and relaxation biolog-
ical properties. The LA is a functioning chamber more
complex than it seems and it is not a LV simple appendix
or a pulmonary vein final chamber but an structure with
direct implication on the heart rhythm, on the pulmonary
circulation and on the LV filling modulation, with a
defined clinical importance and has been largely dis-
cussed in the real scenario in the heart failure syndrome,
systemic arterial hypertension clinical context, and even
in normal, athletic or sedentary patients [50]. EvenCardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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though it is a multifunctional structure, its property used
to contract and propel volume to the LV is always the one
referred to when someone evaluates the LA participation
in the cardiac cycle. However, the pump function has a
discrete importance in patients with normal LV and its
contraction function is more necessary in physical exercise
situations. The amount of contribution of the atrial sys-
tole for the LV function is controversial, depending on the
LV own function and the heart rate, and this will influence
in the increase of the LV systolic and diastolic efficiency.
In other words, the LA contraction acts like an auxiliary
propeller which increases the ventricular systolic volume
by the increase of the LV volume and diastolic pressure
using the Frank-Starling mechanism. In pathological situ-
ations, the pump becomes of compensatory real impor-
tance in relaxation dysfunction states and/or ventricular
compliance, maintaining a LV minimum filling volume
and a normal LA pressure [51]. The reservoir function is
also relevant. The chamber operates as storage at the end
of the line for the pulmonary venous flow, a predominant
factor for the generation of enough atrial pressure to pro-
duce a LA-LV gradient, a phenomenon which is necessary
for the LV early filling when the repletion of 80% of the
diastolic volume happens in normal conditions. There-
fore, the greater the capacity to preserve volume, greater
will be the energetic contribution for the atrial systole,
considering the Frank-Starling mechanism one more time
[50]. The reservoir mechanism by which the LA works is
the function of the relaxation, the left atrial complacence
and the LV longitudinal shortening. In the CF caused by
ischaemia or mitral regurgitation, this reservoir can oper-
ate by accommodating volume and pressure, acting as a
pulmonary circulation protector, at least for a certain
time. At the very last, the LA acts as a simple flow conduct
for the LV. The chamber assumes this propriety in two
moments: an early phase, during the ventricular relaxa-
tion and mitral valve opening and in a later phase
between the early ventricular filling and the late one, act-
ing as a linking direct conduct between the pulmonary
veins and the LV taking the advantage of the open mitral
valve. In this last case, the flow happens due to the atrial-
venous gradient difference and it only occurs in low heart
rate situations [52]. The LA works predominantly as a con-
duct in opposing clinical situations for the normal indi-
vidual, in which the reservoir function or the atrial
contraction is not that important or in situations of
extreme increase in the diastolic pressure and/or LV stiff-
ness in which the atrial systole cannot contribute anymore
to the ventricular filling due to the LV pressure/volume
high relation. To conclude, it seems more rational to con-
sider the reservoir properties, conduct and contraction as
a LA unique function due to the much interdependence
among them [52,53]. This function synthesizes the auxil-
iary pump important role for the LV and due to its protec-
tive action for the pulmonary circulation, from a
regulative dam to pulmonary circulation.
The left atrium and its interaction with the 
diastolic function and left ventricular 
remodeling: the evidences and its clinical 
applicability
The remodeling indices and the left atrial function have
already been related to systemic arterial hypertension, age
and a variety of other situations, and the interaction with
the LV function represents an important focus of interest
to understand the CF myocardial physiopathology. The
left atrium contractile function is the most emphasized
item when this issue is discussed – LA and the LV func-
tion. The awareness regarding the contribution of the
atrial systole for the increase of the relation LV pressure/
final diameter has opened new perspectives for the under-
standing of the geometry relation model, the left atrium
function and its relation with the LV [54]. Kono et al. find-
ings [55], in an animal sample of CF induced by coronary
embolization, have demonstrated a significant LA
increase dimension from the beginning to 33 weeks after
the induced CF (2.4 ± 0.2 cm × 3.3 ± 0.3 cm, P < 0.01).
The systolic function has also been affected and its short-
ening fraction has worsened in the period (22 ± 3% × 15
± 2%, P < 0.01). Both alterations were associated with the
significant worsening of the LV filling TMD pattern. The
author has concluded that a LA dimension increase
should represent a compensation for the LV early filling
decrease in the induced CF. Additionally, the worsening
of the shortening fraction would be a reflex of the LA con-
tractile compensation early failure regarding the more
adverse LV pressure and volume conditions. This publica-
tion is highly illustrative as it approaches a classical profile
of the post-ischaemic CF and the results converge to an
understanding of the prognosis power after AMI of the LA
volume indices which have been demonstrated recently
[56]. Another urging issue to be analysed, is the study of
the LA geometric and functional index relationship with
LV filling pressure measures. Appleton et al. [57] have
investigated 70 patients with probable ischaemic heart
disease submitted to cardiac catheterization and to an
echocardiography evaluation with Doppler of the left
atrium and the LV diastolic function. One of the objec-
tives was to estimate the LV filling pressure using echocar-
diographic study with Doppler and the additional value
of the dimension indices and the left atrium function in
this prediction. The results have revealed a significant cor-
relation between the average pulmonary capillary pres-
sure and the LA volume (r = 0.70) and a 82% sensitivity
with 92% specificity, so that the minimum left atrial vol-
ume > 40 ml could estimate an average pulmonary capil-
lary pressure of 12 mmHg. This study reveals important
homodynamic evidences, as the filling pressure can be
considered an excellent comparison pattern and well cor-Cardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
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related with the clinical symptoms, therefore being able to
suggest clinical relevance for the atrial volume indices
measured by echocardiography. Following the clinical
approach, it is important to mention that systemic arterial
hypertension represents one of the highest stimuli for
heart structural disease.
However, what would be the correlation between the atri-
oventricular remodeling variables, LV myocardial dys-
function by pressure overload in heart adaptation initial
stages to systemic arterial hypertension? In an attempt to
clarify this question, a study by Tsioufis et al. [58] has
shown in a group of 94 patients with primary SAH in
stages I and II, comparing to 34 controls without hyper-
tension, a higher index of the LV mass (105 g/m2 × 84 g/
m2, P < 0.001), a larger LA diameter (39 mm × 36 mm, P
< 0.001), and a bulkier LA (22 × 19 ml/m2, P < 0.05). In
the hypertensive population, the LA volume index corre-
lates significantly with the LV mass index, pulse pressure,
systolic pressure level and natriuretic peptide. It is relevant
to call the attention to the idea that hypertension is a
dominant factor in such referred population of elderly
people with their hearts insufficiently dependable to pre-
serve contractile function. Another article published by a
group from the Wake Forest University [59] has studied the
volume relationship geometry and left atrial function in
the diastolic and systolic CF population of 851 elderly
subjects > 65 years. The authors have observed that the
volume, the area and the linear dimensions were higher in
the CF incident and more dominant groups in relation to
the control group and have not seen differences during
the follow up periods of groups with diastolic versus the
systolic cardiac failure.
These findings emphasize the importance of the left
atrium as an actor in CF patients independently of the case
of depressed or preserved LV ejection fraction, validating
the applicability of this parameter in patients in this age
group with diastolic CF. In short, it is possible to state that
there is some evidence support which points out to a clear
idea of an interaction between the geometry data and the
LV and LA function. The next step is to establish and to
quantify the importance of all information for clinical
handling. And, more recently, in agreement with this idea,
many studies were published, transcending concepts
obtained in a transversal way for studies of longitudinal
follow up which emphasized this issue relevance. In at
least four studies published in the last time, a left atrial
index prognostic correlation could be observed. Tsang et
al. [60] have observed that increased atrial indices pre-
sented a prognosis prediction value very significant for
cardiovascular events in a population of 317 individuals
in sinus rhythm, where the left atrium volume index has
obtained the best performance (area under the ROC curve
0.71 for the LA volume index and 0.59 for the LA diame-
ter). In another publication of the group from the Mayo
Clinic, in which a cohort from Olmsted, Minnesota, USA
was investigated with 1,375 elderly people (≥ 65 years of
age) with preserved systolic function (≥ 50% of LV ejec-
tion fraction), it was identified that a left atrial volume ≥
32 ml/m2 was an independent predictor for the first man-
ifestation of CF (P < 0.001) in a follow up of 4.3 ± 2.7
years of age and a higher LA volume progression (8 ± 10
ml, P < 0.001) was observed in follow up of people who
developed CF [61]. There are evidences pointing out that
maintenance of the left atrial contraction function has a
better prognosis. Echocardiographic data from 2,808 mid-
dle age individuals and elderly ones of the population-
based study The Strong Heart Study [62] conducted in
North-American Indians has revealed that the elevated LA
systolic strength (90 percent) was associated with a higher
rate of combined cardiovascular events even though with
a modest effect proportion, but statistically important
(HR = 1.33, CI 95%, 1.05 – 1.61; P = 0.021), besides being
associated with geometric changes and heart functions.
This was an original finding which has enriched the
knowledge on the atrial function as the clinical prognosis
marker in the primary prevention context of cardiac
events among them the CF patients. Another publication
involving the same group of people aimed at correlating
the simple left atrial diameter measure with the incidence
of combined cardiovascular events. In this analysis, an
increase in the atrial diameter (4.2 cm for men and 3.8 cm
for women) was an independent risk predictor for the first
episode of combined cardiovascular events (HR = 1.57, CI
95% = 1.17 – 2, P = 0.002). When analysing data from this
later study, someone may come to the conclusion that the
abnormal LA has identified a population with more prev-
alent heart dysfunction, with LV relaxation abnormalities
and a most elevated filling pressure level. Besides, changes
of the LA geometry joined the production of natriuretic
peptide and have a direct relationship with atrial fibrilla-
tion genesis and other arrhythmia and these ones with the
formation of embolus inducing cerebral ischaemia [63].
Studies also suggest that the echocardiographic variables
of the LA may predict a higher susceptibility of such
patients and should be the reason or basis for more
aggressive approaches of a primary prevention [64]. As in
hypertensive groups, some previous works have shown an
atrial growth reversion with anti-hypertensive adequate
therapy, probably, so, the evidence of the atrium data use
in the diastolic heart function evaluation is clear, and
despite the LA volume index superiority, the simple diam-
eter measure is also associated with the cardiovascular
prognosis.
Atrioventricular remodeling and diastole: a 
combined analysis
The diagnostic evaluation of the patient with a suspicion
of CF is not always simple, mainly when there is a normalCardiovascular Ultrasound 2008, 6:56 http://www.cardiovascularultrasound.com/content/6/1/56
Page 11 of 13
(page number not for citation purposes)
or slightly altered LV ejection fraction, since this is the case
in half of the CF cases. The echocardiographic tools for
diastolic evaluation, despite the improvement already
attained, sometimes are not enough if they are analyzed
separately (Figure 5). The LV and LA remodeling data
already fulfill the gaps left by Doppler and allow a more
complete diagnosis characterization, gathering prognosis
information. The consideration of validated indices like
the LV mass index, the LV eccentric or concentric hypertro-
phy pattern, the left atrial volume index or the LA diame-
ter in the diagnosis analysis can represent a fine
adjustment fully tuned up with the tendency mentioned
in clinical studies.
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Left ventricle diastolic analysis in CF patients Figure 5
Left ventricle diastolic analysis in CF patients.
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